SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets
ULBI 5.660+2.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: richardred who wrote (2274)7/17/2010 2:46:41 PM
From: richardred  Read Replies (1) of 7252
 
Botox-maker Allergan is takeover target?
July 2nd, 2010, 11:35 am · Post a Comment · posted by Colin Stewart

The possible purchase of Allergan is a top topic on this blog’s Facebook page, where all are welcome to visit for news and gossip before it reaches the blog.

Irvine-based Allergan, the manufacturer of wrinkle-fighters Botox and Juvederm, breast implants, eyelash-enhancer Latisse and much more, is a profitable mid-sized company that’s often rumored to be a takeover target.

The latest possible buyer is French pharmaceutical company Sanofi-Aventis SA, which Reuters said is looking to buy an American company — maybe Allergan, but perhaps Biogen, Genzyme, or any of four other companies, according to the Wall Street Journal.

Sanofi-Aventis makes a broad range of drugs, including Plavix, but has little or no presence in the cosmetic-medical market.
inyourface.ocregister.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext